An infographic presented by the AHNS Basic and Translational Science Service. The promise and uncertainties of applying the new neoadjuvant anti-PD1 standard created by KEYNOTE-689
#AHNS #AHNS #neoadjuvant #immunotherapy #HNSCC
KN689 Infographic
Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.